Active surveillance of adverse events following immunization against pandemic influenza A (H1N1) in Korea

Japanese Journal of Infectious Diseases

Volumn 64, Issue 4, 2011, Pages 297-303

  Choe, Young June ^a   Cho, Heeyeon ^a   Song, Kyung Min ^a   Kim, Jong Hee ^a   Han, Ok Pil ^a   Kwon, Yoon Hyung ^a   Bae, Geun Ryang ^a   Lee, Hoan Jong ^c   Lee, Jong Koo ^b  

^a Division of Vaccine Preventable Disease Control   (South Korea)

^b Korea Centers for Disease Control and Prevention   (South Korea)

^c Seoul National University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ADJUVANT; INFLUENZA VACCINE;

2009 H1N1 INFLUENZA; ADULT; AGED; ARTHRALGIA; ARTICLE; CHILL; DRUG SAFETY; DRUG SURVEILLANCE PROGRAM; DYSPNEA; FEMALE; FEVER; HEADACHE; HUMAN; INFLUENZA VACCINATION; INJECTION SITE ERYTHEMA; INJECTION SITE INDURATION; INJECTION SITE PAIN; INTERVIEW; KOREA; LIMB WEAKNESS; MAJOR CLINICAL STUDY; MALE; MYALGIA; NAUSEA; PARESTHESIA; PRURITUS; SEIZURE; SYNCOPE; TELEPHONE; TREMOR; URTICARIA; VOMITING; WEAKNESS;

ADJUVANTS, IMMUNOLOGIC; ADOLESCENT; ADULT; ADVERSE DRUG REACTION REPORTING SYSTEMS; AGED; CHILD; CHILD, PRESCHOOL; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; INFANT; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA VACCINES; INFLUENZA, HUMAN; INTERVIEWS AS TOPIC; MALE; MIDDLE AGED; PANDEMICS; PREGNANCY; QUESTIONNAIRES; REPUBLIC OF KOREA; VACCINATION; YOUNG ADULT;

EID: 79961012884     PISSN: 13446304     EISSN: 18842836     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Ehreth, J. (2003): The global value of vaccination. Vaccine, 21, 596-600.
2. Plotskin, S.A. and Orensterin, W.A. (2008): Vaccines. 5th ed. WB Saunders Co., Pa.
3. Chen, R.T., Rastogi, S.C., Mullen, J.R., et al. (1994): The vaccine adverse event reporting system (VAERS). Vaccine, 12, 542-550.
4. Fine, P.E. (1993): Herd immunity: history, theory, practice. Epidemiol. Rev., 15, 265-302.
5. Ellenberg, S.S. and Braun, M.M. (2002): Monitoring the safety of vaccines: assessing the risks. Drug Saf., 25, 145-152.
6. Carrat, F. and Flahault, A. (2007): Influenza vaccine: the challenge of antigenic drift. Vaccine, 25, 6852-6862.
7. Centers for Disease, Control and Prevention (2009): Use of influenza A (H1N1) 2009 monovalent vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP). Morbid. Mortal. Wkly. Rep., 58(RR-10), 1-8.
8. Alberti, K.G. (2001): Medical errors: a common problem. Br. Med. J., 322, 501-502.
9. Zhou, W., Pool, V., Iskander, J.K., et al. (2003): Surveillance for safety after immunization: Vaccine Adverse Event Reporting System (VAERS)-United States, 1991-2001. Morbid. Mortal. Wkly. Rep., 52(SS-1), 1-24.
10. Netterlid, E., Mansson, M.E. and Hakansson, A. (2009): Surveillance of vaccine safety: comparison of parental reports with routine surveillance and a clinical trial. Vaccine, 27, 2042-2047.
11. Cho, H.Y., Kim, C.H., Go, U.Y., et al. (2010): Immunization decision-making in the Republic of Korea: the structure and functioning of the Korea Advisory Committee on Immunization Practices. Vaccine, 28(S), A91-A95.
12. Ministry of Health (2009): Prevention of Contagious Disease Act. Korean Centers for Disease Control and Prevention, Seoul.
13. o18 years of age: a prospective, open-label, multi-center trial. Vaccine, 28, 5857-5863.
14. Choi, W.S., Kim, W.J. and Cheong, H.J. (2010): The evaluation of policies on 2009 influenza pandemic in Korea. J. Prev. Med. Public Health, 43, 105-108 (text in Korean with English summary).
15. Choi, W.S. and Kim, W.J. (2009): Vaccine strategy for influenza A (H1N1) pandemic. Infect. Chemother., 41, 259-264.
16. Partridge, J. and Kieny, M.P. (2010): Global production of seasonal and pandemic (H1N1) influenza vaccines in 2009-2010 and comparison with previous estimates and global action plan targets. Vaccine, 28, 4709-4712.
17. Patja, A., Paunio, M., Kinnunen, E., et al. (2001): Risk of Guillain-Barrésyndrome after measles-mumps-rubella vaccination. J. Pediatr., 138, 250-254.
18. Vajo, Z., Tamas, F., Sinka, L., et al. (2010): Safety and immunogenicity of a 2009 pandemic influenza A H1N1 vaccine when administered alone or simultaneously with the seasonal influenza vaccine for the 2009-10 influenza season: a multicentre, randomised controlled trial. Lancet, 375, 49-55.
19. Liang, X.F., Wang, H.Q., Wang, J.Z., et al. (2010): Safety and immunogenicity of 2009 pandemic influenza A H1N1 vaccines in China: a multicentre, double-blind, randomised, placebo-controlled trial. Lancet, 375, 56-66.
20. Nichol, K.L., Margolis, K.L., Lind, A., et al. (1996): Side effects associated with influenza vaccination in healthy working adults. A randomized, placebo-controlled trial. Arch. Intern. Med., 156, 1546-1550.
21. Govaert, T.M., Dinant, G.J., Aretz, K., et al. (1993): Adverse reactions to influenza vaccine in elderly people: randomised double blind placebo controlled trial. Br. Med. J., 307, 988-990.
22. Allsup, S.J., Gosney, M., Regan, M., et al. (2001): Side effects of influenza vaccination in healthy older people: a randomised single-blind placebo-controlled trial. Gerontology, 47, 311-314.
23. Margolis, K.L., Nichol, K.L., Poland, G.A., et al. (1990): Frequency of adverse reactions to influenza vaccine in the elderly. A randomized, placebo-controlled trial. JAMA, 264, 1139-1141.
24. Lester, R.T., McGeer, A., Tomlinson, G., et al. (2003): Use of, effectiveness of, and attitudes regarding influenza vaccine among house staff. Infect. Control Hosp. Epidemiol., 24, 839-844.
25. Tamma, P.D., Ault, K.A., del Rio, C., et al. (2009): Safety of influenza vaccination during pregnancy. Am. J. Obstet. Gynecol., 201, 547-552.
26. Mak, T.K., Mangtani, P., Leese, J., et al. (2008): Influenza vaccination in pregnancy: current evidence and selected national policies. Lancet Infect. Dis., 8, 44-52.
27. Isaacs, D., Lawrence, G., Boyd, I., et al, (2005): Reporting of adverse events following immunization in Australia. J. Paediatr. Child Health, 41, 163-166.
28. Varricchio, F., Iskander, J., Destefano, F., et al, (2004): Understanding vaccine safety information from the Vaccine Adverse Event Reporting System. Pediatr. Infect. Dis. J., 23, 287-294.
29. Wu, J., Xu, F., Lu, L., et al. (2010): Safety and effectiveness of a 2009 H1N1 vaccine in Beijing. N. Engl. J. Med., 363, 2416-2423.